Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Treatment interruption in a primary care antiretroviral therapy program in South Africa: Cohort analysis of trends and risk factors
Journal of Acquired Immune Deficiency Syndromes, Volume 55, No. 3, Year 2010
Notification
URL copied to clipboard!
Description
Objective: To investigate antiretroviral treatment (ART) interruption in a long-term treatment cohort in South Africa. Methods: All adults accessing ART between 2004 and 2009 were included in this analysis. Defaulting was defined as having stopped all ART drugs for more than 30 days. Treatment interrupters were patients who defaulted and returned to care during the study, whereas loss to follow-up was defined as defaulting and not returning to care. Kaplan-Meier estimates and Poisson regression models were used to analyze rates and determinants of defaulting therapy and of treatment resumption. Results: Overall rate of defaulting treatment was 12.8 per 100 person-years (95% confidence interval: 11.4 to 14.4). Risk factors for defaulting were male gender, high baseline CD4 count, recency of ART initiation, and time on ART. The probability of resuming therapy within 3 years of defaulting therapy was 42% (event rate = 21.4 per 100 person-years). Factors associated with restarting treatment were female gender, older age, and time since defaulting. Conclusions: Defaulting treatment need not be an irreversible event. Interventions to increase retention in care should target men, less immunocompromised patients, and patients during the first 6 months of treatment. Resumption of treatment is most likely within the first year of interrupting therapy. © 2010 by Lippincott Williams & Wilkins.
Authors & Co-Authors
Kranzer, Katharina A.
Unknown Affiliation
Lewis, James J.C.
Unknown Affiliation
Ford, Nathan P.
Unknown Affiliation
Zeinecker, Jennifer
Unknown Affiliation
Orrell, Catherine J.
Unknown Affiliation
Lawn, Stephen D.
Unknown Affiliation
Bekker, Linda-Gail Gail
Unknown Affiliation
Wood, Robin Y.
Unknown Affiliation
Statistics
Citations: 122
Authors: 8
Affiliations: 4
Identifiers
Doi:
10.1097/QAI.0b013e3181f275fd
ISSN:
15254135
Study Design
Cohort Study
Study Locations
South Africa
Participants Gender
Male
Female